G. Nickless

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study

T. Barbui, S. Schnittger, P. Guglielmelli, 2013, Leukemia.

Guidelines for the measurement of BCR‐ABL1 transcripts in chronic myeloid leukaemia

N. Cross, H. White, L. Foroni, 2011, British journal of haematology.

A certi fi ed plasmid reference material for the standardisation of BCR – ABL1 mRNA quanti fi cation by real-time quantitative PCR

D. Colomer, T. Lion, M. Jansson, 2015 .

Screening for EGFR and KRAS Mutations in Endobronchial Ultrasound Derived Transbronchial Needle Aspirates in Non-Small Cell Lung Cancer Using COLD-PCR

E. Mclean, J. Spicer, K. Tobal, 2011, PloS one.

A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR

H Emons, V Kairisto, S Trapmann, 2014, Leukemia.

Systematic Evaluation of DNA-Based Quantitative-Polymerase Chain Reaction (Q-PCR) Assays to Track Treatment Response in Patients with JAK2-V617F Associated Myeloproliferative Neoplasms: A Joint European LeukemiaNet/ MPN&MPNr-EuroNet Study

T. Barbui, P. Guglielmelli, A. Pancrazzi, 2011 .